06 7月 2021 by admin in UncategorizedComments NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
01 7月 2021 by admin in UncategorizedComments Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
28 6月 2021 by admin in UncategorizedComments Tempest Closes Merger with Millendo and Completes PIPE Financing
22 6月 2021 by admin in UncategorizedComments Tempest and Millendo Announce Stockholder Approval of Merger
21 6月 2021 by admin in UncategorizedComments NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
07 6月 2021 by admin in UncategorizedComments Design Therapeutics Expands Board of Directors with Key Appointments
